Showing results (551-560 of 610) with videos related to
Sort By:
Pageof 61
Cell Death and Differentiation|June 30, 2012
Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicityJ Parcq, T Bertrand, A Montagne, et al.Circulation|April 1, 1989
Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysisI K Jang, H K Gold, A A Ziskind, et al.Journal of the American College of Cardiology|September 1, 1990
Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparationT Yasuda, H K Gold, H Yaoita, et al.Journal of the American College of Cardiology|December 1, 1990
Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibodyT Yasuda, H K Gold, R C Leinbach, et al.Circulation|September 17, 1998
Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigsO Varenne, S Pislaru, H Gillijns, et al.Circulation|October 15, 1995
A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial GroupS Vanderschueren, L Barrios, P Kerdsinchai, et al.Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activatorT H Bugge, M J Flick, M J Danton, et al.Lancet (London, England)|April 13, 1985
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen ActivatorM Verstraete, R Bernard, M Bory, et al.Journal of the American College of Cardiology|April 1, 1988
Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiographyH D Garabedian, H K Gold, T Yasuda, et al.The Journal of Clinical Investigation|August 1, 1990
Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectorisH K Gold, L W Gimple, T Yasuda, et al.Pageof 61